X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

April 30, 2019

Particles in Parenteral Drug Products - Measuring and Mitigating

Particles in parenteral drug products are a serious concern; they can cause issues such as product recalls, or worse, immunogenic responses. Sources of particles are varied; they can be from aggregates of biologic API’s, excipient contaminants, components, or silicone oil used to promote syringe function. With emphasis on safe and efficient delivery of drug products, West is focused on strategies to both measure particles, and mitigate their presence.
Ranjana Singh

Ranjana Singh

Sr. Scientist, Insight Labs

Previous Posts
Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Compatibility issues Chart

March 07, 2019

Simplify the Journey™ - Integrated Solutions for Particles

Doug Hostetler

Doug Hostetler

Sr Manager, Integrated Solutions, Lab

Particle Testing

March 01, 2019

Achieving ″Zero″ Defects for Visible Particles in Injectables

Olga Laskina

Olga Laskina

Sr Tech Acct Spec, TCS, NA

Leur Lock Syringes

February 25, 2019

Particles in Intravitreal Injections - Part II

Susan Dounce

Susan Dounce

Principal SME, PFS CZ, TCS

Analytical Laboratory

February 22, 2019

West Analytical Services Introduces New Particle Testing Capabilities

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Two scientists in the lab

February 20, 2019

Particles in Intravitreal Injections - Part I

Susan Dounce

Susan Dounce, PhD

Principal SME, Pre-filled Syringes

Load more